[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100382485":3},{"organization":4,"outcomesModule":7,"designInfo":18,"detailedDescription":27,"studyPopulation":17,"armGroups":28,"interventions":41,"overallOfficials":48,"centralContacts":52,"locations":17,"responsibleParty":63,"collaborators":17,"id":67,"slug":17,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":68,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":17,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":17,"overallStatus":86,"whyStopped":17,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":17},{"fullName":5,"class":6},"Cardenal Herrera University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":17},[9],{"measure":10,"description":11,"timeFrame":12},"Quality of life measured with the Chronic Obstructive Pulmonary Disease Assessment Test: Score","Score (0-40) higher scores mean a worse outcome.","3 weeks",[14],{"measure":15,"description":16,"timeFrame":12},"6 Minutes Walking Test","Maximum distance reached",null,{"allocation":19,"interventionModel":20,"interventionModelDescription":17,"primaryPurpose":21,"observationalModel":17,"timePerspective":17,"maskingInfo":22},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":23,"maskingDescription":17,"whoMasked":24},"DOUBLE",[25,26],"PARTICIPANT","OUTCOMES_ASSESSOR","So far, there are no previous studies that analyze the effects of a myofascial relaxation protocol applied to the diaphragm within the respiratory rehabilitation treatment in patients with chronic obstructive pulmonary disease.\n\nAim: The main objective of this study is to assess the effects of a 3 weeks myofascial release protocol applied to the diaphragm on respiratory parameters in patients with chronic obstructive pulmonary disease.\n\nDesign: Randomized clinical trial",[29,35],{"label":30,"type":31,"description":32,"interventionNames":33},"Sham Myofascial + Respiratory rehabilitation","SHAM_COMPARATOR","Respiratory rehabilitation programme + sham Myofascial Release",[34],"Other: Sham Myofascial + Respiratory rehabilitation",{"label":36,"type":37,"description":38,"interventionNames":39},"Experimental-Myofascial + Respiratory rehabilitation","EXPERIMENTAL","Respiratory rehabilitation programme + Myofascial Release",[40],"Other: Experimental-Myofascial + Respiratory rehabilitation",[42,45],{"type":6,"name":36,"description":43,"armGroupLabels":44,"otherNames":17},"6 sessions of: Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)",[36],{"type":6,"name":30,"description":46,"armGroupLabels":47,"otherNames":17},"6 sessions of: Sham Myofascial Release (20 minutes each) + Respiratory rehabilitation (60 minutes each)",[30],[49],{"name":50,"affiliation":5,"role":51},"JUAN FRANCISCO L PÁRRAGA","STUDY_CHAIR",[53,59],{"name":54,"role":55,"phone":56,"phoneExt":57,"email":58},"MARÍA DOLORES ARGUISUELAS, PhD","CONTACT","961369000","64352","doloresarguisuelas@uchceu.es",{"name":60,"role":55,"phone":61,"phoneExt":17,"email":62},"JUAN FRANCISCO L PÁRRAGA, PhD","618055092","juanfran@uchceu.es",{"type":64,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"PRINCIPAL_INVESTIGATOR","ARGUISUELAS MARTINEZ MARÍA DOLORES","Head of Physiotherapy","100382485",false,"NCT04260243","Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease","Effects of Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease: a Randomized Clinical Trial","MFR-COPD","Inclusion Criteria:\n\n* COPD;\n* Forced expiratory volume in the first second (FEV1) \\\u003C 80%;\n* FEV1\u002FForced vital capacity (FVC) \\\u003C 70%;\n* Maximal inspiratory pressure (MIP) \\\u003C 70%.\n\nExclusion Criteria:\n\n* Recent (6 months) spine or abdominal surgery;\n* Allergic status of any kind;\n* systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);\n* neuromuscular or neurological injuries;\n* previous myofascial release treatment.","ALL","18 Years","75 Years",{"count":78,"type":79},30,"ESTIMATED","INTERVENTIONAL",[82],"NA","The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).",[85],"Copd","NOT_YET_RECRUITING","2025-02-10",{"date":89,"type":90},"2025-02-12","ACTUAL",{"date":92,"type":79},"2026-03",{"date":94,"type":79},"2027-06",{"name":5,"class":6}]